Targeting of Drugs 5 1996
DOI: 10.1007/978-1-4615-6405-8_4
|View full text |Cite
|
Sign up to set email alerts
|

Oligonucleotides: Molecular Versions for Optimal use in Vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1998
1998
2004
2004

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 6 publications
0
1
0
Order By: Relevance
“…While xenobiotics are normally taken up by passive diffusion, considering the size of peptide-BSA-gold conjugates, passive diffusion is an unlikely translocation mechanism here. Pinocytosis and receptor-mediated endocytosis (RME) are the prime mechanisms for the uptake of large molecular structures (28). Cellular uptake of nanoparticles coated with peptide-BSA conjugates could occur by RME, or for the Tat RKKRRQRRR sequence, via the less understood peptide transduction domain mechanism (PTD).…”
Section: Preparation Of Gold Nanoparticle Vectorsmentioning
confidence: 99%
“…While xenobiotics are normally taken up by passive diffusion, considering the size of peptide-BSA-gold conjugates, passive diffusion is an unlikely translocation mechanism here. Pinocytosis and receptor-mediated endocytosis (RME) are the prime mechanisms for the uptake of large molecular structures (28). Cellular uptake of nanoparticles coated with peptide-BSA conjugates could occur by RME, or for the Tat RKKRRQRRR sequence, via the less understood peptide transduction domain mechanism (PTD).…”
Section: Preparation Of Gold Nanoparticle Vectorsmentioning
confidence: 99%